QIAGEN N.V. Files 6-K on Annual Shareholder Meeting

Ticker: QGEN · Form: 6-K · Filed: Aug 2, 2024 · CIK: 1015820

Qiagen N.V. 6-K Filing Summary
FieldDetail
CompanyQiagen N.V. (QGEN)
Form Type6-K
Filed DateAug 2, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: shareholder-meeting, foreign-private-issuer, sec-filing

Related Tickers: QGEN

TL;DR

QGEN filed its 6-K for the June 30, 2024 period, detailing its Annual General Meeting materials.

AI Summary

QIAGEN N.V. filed a Form 6-K on August 2, 2024, reporting on its Annual General Meeting of Shareholders held on June 21, 2024. The filing includes related materials as exhibits, incorporated by reference.

Why It Matters

This filing provides shareholders with official documentation and materials related to the company's annual general meeting, ensuring transparency and compliance.

Risk Assessment

Risk Level: low — The filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information that would typically increase risk.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is a report of a foreign private issuer filed to furnish materials related to QIAGEN N.V.'s Annual General Meeting of Shareholders held on June 21, 2024.

When was the Annual General Meeting of Shareholders held?

The Annual General Meeting of Shareholders was held on June 21, 2024.

What is the reporting period for this 6-K?

The conformed period of report for this 6-K filing is June 30, 2024.

Where is QIAGEN N.V. incorporated and what is its fiscal year end?

QIAGEN N.V. is incorporated in P7 and its fiscal year ends on December 31.

What exhibits are included with this 6-K filing?

The filing includes related materials as Exhibits 99.1 to 99.7, which are incorporated by reference.

Filing Stats: 233 words · 1 min read · ~1 pages · Grade level 7.7 · Accepted 2024-08-01 21:07:17

Filing Documents

Signatures

Signatures 4 Exhibit Index 5 Other Information On June 21, 2024, QIAGEN N.V (NYSE QGEN Frankfurt Prime Standard QIA) held the Annual General Meeting of Shareholders. The related materials are furnished herewith as Exhibit 99.1 to 99.7 and are incorporated by reference herein. 3

Signatures

Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized. QIAGEN N.V. By s Roland Sackers Roland Sackers Chief Financial Officer Date August 1, 2024 4 Exhibit Index Exhibit No. Exhibit 99.1 Notice 2024 AGM QIAGEN N.V. 99.2 Proxy Statement 2024 99.3 Beneficial Shareholder Attendance Form 2024 99.4 Registered Shareholder Attendance Form 2024 99.5 Proxy Card for 2024 Annual General Meeting of Shareholders 99.6 2024 QIAGEN AGM Voting Results 99.7 2023 IFRS Annual Report 5

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing